Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-033994

Director sold 600,000 shares at $8.45 ($5,070,000)

From the SEC's structured data for this filing

Trades in this filing

Hallal David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-10-19 Sale : show line 1 in the form −600,000 $8.45 $5,070,000 138,153 I
Open-market sales · 600,000 sh · avg $8.45 · $5,070,000
Loading xslF345X03/doc4.xml…